Detection of T lymphocyte subsets and mIL-2R on surface of PBMC in patients with hepatitis B

被引:31
作者
Wang, KX [1 ]
Peng, JL [1 ]
Wang, XF [1 ]
Tian, Y [1 ]
Wang, J [1 ]
Li, CP [1 ]
机构
[1] Anhui Univ Sci & Technol, Sch Med, Dept Etiol & Immunol, Huainan 232001, Anhui, Peoples R China
关键词
D O I
10.3748/wjg.v9.i9.2017
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To study the levels of T lymphocyte subsets and membrane interleukin-2 receptor (mIL-2R) on surface of peripheral blood mononuclear cells (PBMCs) of patients with hepatitis B and its role in the pathogenesis of hepatitis B. METHODS: The levels of T lymphocyte subsets and mIL-2R in PBMC before and after being stimulated with PHA were detected by biotin-streptavidin (BSA) technique in 196 cases of hepatitis B. RESULTS: In patients with hepatitis B, the levels of CD3+, CD4+ cells, and the ratio of CD4+ cells/CD8+ cells were lower, but the level of CD8+ cells was higher than those in normal controls (42.20+/-6.01 vs 65.96+/-654, 38.17+/-5.93 vs 41.73+/-6.40, 0.91+/-0.28 vs 1.44+/-0.31, 39.86+/-6.36 vs 30.02+/-4.54, P<0.01). The total expression level of mIL-2R in PBMC before and after being stimulated with PHA was also lower than those in normal controls (3.47+/-1.55 vs 4.52+/-1.49, 34.03+/-2.94 vs 37.95+/-3.00, P<0.01). In all the patients with hepatitis B, the levels of T lymphocyte subsets and mIL-2R in PBMC with HBV-DNA (+) were lower than those with HBV-DNA (-), which were significantly different (39.57+/-7.11 vs44.36+/-5.43, 34.36+/-7.16 vs 40.75+/-5.87, 37.82+/-6.54 vs 41.72+/-6.21, 0.88+/-0.33 vs 0.99+/-0.27, 2.82+/-1.62 vs 3.85+/-1.47, 31.56+/-3.00 vs 35.84+/-2.83, P<0.01). In addition, the levels of CD3+, CD4+, CD8+ cells, the ratio of CD4+ cells /CD8+ cells and mIL-2R among different courses of hepatitis B were all significantly different (F=3 723.18, P<0.01. F=130.43, P<0.01. F=54.01, P<0.01. F=2.99, P<0.05. F=7.16, P<0.01). CONCLUSION: Both cellular and humoral immune functions are obviously in disorder in patients with hepatitis B, which might be closely associated with the chronicity in patients.
引用
收藏
页码:2017 / 2020
页数:4
相关论文
共 51 条
[1]
Mechanism of action of vaccine therapy in murine hepatitis B virus carriers: vaccine-induced activation of antigen presenting dendritic cells [J].
Akbar, SMF ;
Abe, M ;
Masumoto, T ;
Horiike, N ;
Onji, M .
JOURNAL OF HEPATOLOGY, 1999, 30 (05) :755-764
[2]
Bernardi Mauro, 2002, Recenti Progressi in Medicina, V93, P397
[3]
Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections [J].
Bertoletti, A ;
DElios, MM ;
Boni, C ;
DeCarli, M ;
Zignego, AL ;
Durazzo, M ;
Missale, G ;
Penna, A ;
Fiaccadori, F ;
DelPrete, G ;
Ferrari, C .
GASTROENTEROLOGY, 1997, 112 (01) :193-199
[4]
Bertoletti A, 1996, Acta Biomed Ateneo Parmense, V67, P87
[5]
Altered expression of hepatic carcinogen metabolizing enzymes with liver injury in HBV transgenic mouse lineages expressing various amounts of hepatitis B surface antigen [J].
Chemin, I ;
Ohgaki, H ;
Chisari, FV ;
Wild, CP .
LIVER, 1999, 19 (02) :81-87
[6]
Nondeletional T-cell receptor transgenic mice:: Model for the CD4+ T-cell repertoire in chronic hepatitis B virus infection [J].
Chen, M ;
Sällberg, M ;
Thung, SN ;
Hughes, J ;
Jones, J ;
Milich, DR .
JOURNAL OF VIROLOGY, 2000, 74 (16) :7587-7599
[7]
Modeling the T-helper cell response in acute and chronic hepatitis B virus infection using T-cell receptor transgenic mice [J].
Chen, M ;
Sällberg, M ;
Thung, SN ;
Hughes, J ;
Jones, J ;
Milich, DR .
ANTIVIRAL RESEARCH, 2001, 52 (02) :99-111
[8]
CHROMARAT P, 1998, TOXICOL LETT, V102, P595
[9]
Eyigün CP, 1999, HEPATO-GASTROENTEROL, V46, P1890
[10]
Quantitative monitoring of serum hepatitis B virus DNA and blood lymphocyte subsets during combined prednisolone and interferon-α therapy in patients with chronic hepatitis B [J].
Fei, GZ ;
Sylvan, SPE ;
Yao, GB ;
Hellström, UB .
JOURNAL OF VIRAL HEPATITIS, 1999, 6 (03) :219-227